GET THE APP

..

Virology: Current Research

Open Access

In silico Docking for Inhibition Neuropilin-1 (Sars-Cov-2 Receptor) by Some Natural Compound and Approved Drugs

Abstract

Mohamed Gomaa Seadawy, Mohamed Shamel Eldesoky, Aya Ahmed and Abdel Rahman Nabwi Zekri

Background: Neuropilin-1 (NRP-1) is a multifunctional transmembrane receptor for ligands that affect developmental axonal growth and angiogenesis. Beside its role in cancer, NRP-1 is a reported entrance for several viruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causal agent of coronavirus disease 2019 (COVID-19).

 

Methods: We made Insilco docking between the spike protein and Neuropilin-1 using Cluspro 2.0 software. Therefore, Neuropilin-1 becomes host factor for SARS-CoV-2 infection. Then by using molecular docking, we test nine compounds against Neuropilin-1 for its inhibition.

 

Results and Conclusion: Our study revealed that some drugs and natural compounds success in inhibition of binding between the virus and its new receptor with Insilco docking data. 

PDF

Share this article

tempobet

tempobet giri┼č

tempobet giri┼č

s├╝perbetin

tipobet yeni giri┼č adresi tipobet e yeni giri┼č tipobet g├╝ncel giri┼č adresi imajbet giri┼č adresi

mobilbahis giri┼č

arrow_upward arrow_upward